Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

A boy with severe immune deficiency and Epstein-Barr virus died from high-grade B-cell lymphoma.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

Psoriasis skin changes are complex and might need several biopsies for a clear diagnosis.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Blocking IL-17 signaling may reduce skin inflammation and delay aging.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Claudin-1 and Claudin-3 are crucial for keeping hair follicle structure and preventing a type of hair loss called telogen effluvium.

Human hair follicles have a unique way of using energy and might use the Cori cycle; blocking CCR5 could help treat hair loss.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Blood-derived CD34+ cells speed up healing, reduce scarring, and regrow hair in skin wounds.

Radiotherapy can cause skin fibrosis, which is often overlooked and needs better treatment and evaluation.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Synthetic melanin applied to skin speeds up wound healing.

A new skin disease in four Labrador retrievers responded well to immunosuppressive treatment.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

Symmetrical Acrokeratoderma (SAK) may be a unique skin condition in China, lacking specific treatment and needing long-term monitoring.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Hamilton scale imprecise, hair shaft diameter decreases, stem cell transplant regrows hair, ECP ineffective for alopecia areata universalis.